Daniele Cappellani

9PUBLICATIONS
15CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsCondensed matter characterisation technique developmentAutoimmunityRespiratory diseases
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Dec 31, 2022
Real-life Data on the Effect of Medical Therapy for Amiodarone-induced Thyrotoxicosis on CV Events and Hospitalizations.

Daniele Cappellani, Giulia Marconcini, Luca Manetti

|May 15, 2022
Long-term Efficacy and Safety of Rifampin in the Treatment of a Patient Carrying a CYP24A1 Loss-of-Function Variant.

Alessandro Brancatella, Daniele Cappellani, Martin Kaufmann

|Nov 04, 2021
Hypercalcemia due to CYP24A1 mutations: a systematic descriptive review.

Daniele Cappellani, Alessandro Brancatella, Riccardo Morganti

|Jul 17, 2021
Identification of Two Different Phenotypes of Patients with Amiodarone-Induced Thyrotoxicosis and Positive Thyrotropin Receptor Antibody Tests.

Daniele Cappellani, Giuseppina De Marco, Eleonora Ferrarini

|May 27, 2020
Subcapsular Renal Hematoma in Simultaneous Pancreas Kidney Transplantation.

Daniele Cappellani, Chiara Terrenzio, Elena Gianetti

Pageof 2